HifiSpeaker.wiki | Recent Update | Privacy-Policy | About Us | Contact

Genexxa STAV-3150



Share
Pin
Send
Share
Send
Share

Brand: Genexxa

Genexxa STAV-3150 is a medication that is used for the treatment of prostate cancer. It belongs to a class of drugs called inhibitors of androgen receptor signaling, which work by blocking the effects of male hormones like testosterone that help cancer cells grow and survive. The active ingredient in STAV-3150 is darolutamide, which is an oral medication that can be taken once or twice a day, depending on the dosage prescribed by a healthcare provider. The drug has shown promising results in clinical studies in terms of reducing tumor size, slowing the progression of the disease, and improving overall survival in patients with advanced prostate cancer. However, like all medications, STAV-3150 may cause side effects such as fatigue, weakness, and decreased appetite, which should be discussed with a healthcare provider before starting treatment.



  • Tuning range: FM, MW
  • Power Output: 100W into 8Ω (stereo)
  • Frequency Response: 20Hz to 20kHz
  • Distortion: 0.05%
  • Speaker Impedance: 4Ω (minimum)
  • Input Sensitivity: 2.5mV (mm), 210mV (line)
  • Signal to Noise Ratio: 82dB (mm), 94dB (line)
  • Line Output:
  • Video Connections: composite
  • Dimensions: 140 x 440 x 380 mm
  • Weight: 25 lb
  • Year: 1992
  • Price:

Genexxa STAV-3150

Genexxa STAV-3150

Genexxa STAV-3150

Genexxa STAV-3150

Genexxa STAV-3150

Genexxa STAV-3150

Genexxa STAV-3150

Genexxa STAV-3150



Share
Pin
Send
Share
Send
Share